SBP-103 (Spark BioPharma)

N/A

Report date: 2022/05/10 11:41:04

NME

Base Information

Drug NameSBP-103 (Spark BioPharma)

Drug Alias NameSBP103 Spark BioPharma

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSpark Biopharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A